Physician profile
Deborah E Kortyna
NPI 1750423141
$2,423.30
in general payments reported to CMS, 2019-2025
15 companies · $636 in 2025
The $636 reported for 2025 was more than what 84% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $321 · 2023: $444 · 2024: $1,022 · 2025: $636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,102.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, INC. | $399.01 | 2024-2025 | Rexulti |
| Si-Bone, INC. | $264.70 | 2021-2024 | |
| Genzyme Corporation | $240.88 | 2024 | |
| Neurelis, INC. | $228.09 | 2023-2024 | Valtoco |
| Gilead Sciences, INC. | $191.31 | 2021 | |
| Amgen INC. | $124.98 | 2023 | Repatha |
| Abbvie INC. | $124.76 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $121.36 | 2024 | |
| Pfizer INC. | $120.59 | 2025 | |
| Boston Scientific Corporation | $110.06 | 2024 | Watchman Flx |
| Kyowa Kirin, INC. | $109.43 | 2025 | |
| Tg Therapeutics, INC. | $107.74 | 2023 | |
| Edwards Lifesciences Corporation | $98.42 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.25 | 2025 | |
| Hologic Sales and Service, LLC | $86.72 | 2025 | Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Kortyna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.